Thermo Fisher Scientific Inc.
TMO Healthcare Diagnostics & Research
Thermo Fisher Scientific Inc.’s revenue for fiscal 2025 (year ended December 2025) was $44.6 billion, up 3.91% from fiscal 2024. In the quarter to June 2026, revenue grew 10.5%, EPS grew 9.35%, free cash flow grew 51.8% and total debt rose 18.7%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.
Follow TMO
Thermo Fisher Scientific Inc. (TMO) Free cash flow margin
Thermo Fisher Scientific Inc.'s free cash flow margin over the twelve months to 30 June 2026 was 15.9%, up 1.7 percentage points from fiscal 2025 (14.2%). Over the past ten years it has ranged from 14.2% (fiscal 2025) to 21.2% (fiscal 2020) — the current reading is the lowest in ten years. That is above the Diagnostics & Research industry median of 0.00% and above the Healthcare sector median of 0.00%.
Free cash flow margin, annual
Embed this chart
Annual newest first
| Period | Free cash flow margin | Change (points) |
|---|---|---|
| FY2025 | 14.2% | (2.86) |
| FY2024 | 17.1% | 0.71 |
| FY2023 | 16.4% | 0.93 |
| FY2022 | 15.4% | (1.93) |
| FY2021 | 17.4% | (3.81) |
| FY2020 | 21.2% | 5.19 |
| FY2019 | 16.0% | 0.25 |
| FY2018 | 15.7% | (1.01) |
| FY2017 | 16.8% | 1.21 |
| FY2016 | 15.5% | 0.59 |
Against its own ten years
Free cash flow margin against peers
| Company | Free cash flow margin |
|---|---|
| IDXX IDEXX Laboratories, Inc. compare | 27.2% |
| DHR Danaher Corporation compare | 21.9% |
| MTD Mettler-Toledo International, Inc. compare | 20.9% |
| ILMN Illumina, Inc. compare | 20.7% |
| A Agilent Technologies, Inc. compare | 17.2% |
| TMO Thermo Fisher Scientific Inc. | 15.9% |
| IQV IQVIA Holdings Inc. compare | 13.3% |
| WAT Waters Corporation compare | 7.89% |
| NTRA Natera, Inc. compare | 3.11% |
| Diagnostics & Research industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Free cash flow margin is
Free Cash Flow Margin tells an investor how much of each sale turns into cash the company keeps after paying for investment in its assets.
(Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)) ÷ Revenue
More on TMO
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement